SciLifeLab Anubis

Submit proposals for grants in open calls.

API

In this call, the Drug Discovery and Development Platform (DDD) at SciLifeLab is looking for new project proposals for drug discovery. All therapeutic modalities outlined above are of interest. DDD supports a project portfolio consisting of about 20 programs and we foresee a need to replenish our portfolio with 3-5 new programs this year. We are interested in programs with defined targets for diseases with medical needs. Therapeutic ideas based on technologies that can be extended to other targets and/or other indications are of special interest, i.e. therapeutic platform technologies, as are projects to develop therapeutic molecules with innovative mode-of-actions (e.g., targeted delivery or new modes-of-action for antisense oligonucleotides, small molecules, antibodies and/or proximity-inducers).

The SciLifeLab committee UU opens a call for new equipment, software and/or related personnel aiming to develop SciLifeLab infrastructure services at Uppsala University.

The proposals must give a clear description of the need for the equipment, software and/or related personnel, in addition to a clear description of potential projects and activities that will benefit from the proposal, the relevance to the SciLifeLab research community at large, including actions under the Capabilities (read more) or other current projects facilitated by SciLifeLab infrastructures (read more).

The DDLS Research School opens the call for courses in topics of relevance for data-driven life science research. The DDLS Research School will offer courses (and other activities) to the DDLS PhD students, starting in the spring semester of 2025.

PALS call no 2 (2024)

46 days remaining.

With this call, PALS wants to support and promote scientific interactions between fellows from the different PALS programs (DDLS, SciLifeLab and WCMM) and/or from different organisations within PALS (Chalmers University of Technology, University of Gothenburg, Karolinska Institutet, KTH Royal Institute of Technology, Linköping University, Lund University, Swedish Museum of Natural History, Stockholm University, Swedish University of Agricultural Sciences, Umeå University, Uppsala University). The supported collaborations can involve either a Research project or an Event in all areas of the different programs such as molecular medicine or different areas of life science and can be technology-driven or data-driven projects from fundamental, preclinical, translational, and clinical scientists.

Campus Solna is characterized by a research community actively pushing the envelope of what is technically possible to solve important and complex questions in biology. To address the constant challenge of maintaining and developing state-of-the-art technical infrastructures, seed funding for new initiatives is available.

Annual call for the procurement of common equipment to enhance and maintain the general research capabilities at Campus Solna. Applications for support of up to 1 mkr will be considered. Co-funding strategies are encouraged and RED grant support can be coupled with other financing to acquire equipment exceeding 1 mkr.

SciLifeLab aims to support events within the scope of our fields of research, open to participants from all over Sweden. We aim to encourage collaboration among and between SciLifeLab infrastructure and researchers, as well as with external organizations, and increase awareness of SciLifeLab to the broader research community in Sweden and abroad. A SciLifeLab infrastructure platform/unit or a SciLifeLab group leader must be the organizer or a visible co-organizer.

Detailed information about the call can be found in this document

The unit for Chemical Biology (Chemical Biology Consortium Sweden - CBCS) at SciLifeLab is looking for chemical biology projects to support. We provide world-leading expertise to academic groups across Sweden in a collaborative project model.

This call is intended for projects with a clearly defined need for services from more than one unit of the CBGE platform. The purpose is to investigate the mechanism-of-action and/or molecular targets of small molecules identified in activities such as phenotypic assays or other screening efforts. Projects aimed at understanding the mechanism of existing drugs, or projects in drug repositioning and drug repurposing are equally suitable. Other modalities can be considered.

WASP and DDLS announce a joint call for NESTs (Novelty, Excellence, Synergy, and Teams) projects that span across the thematic profiles of DDLS and WASP. A NEST should address a specific strategic high-priority research challenge with international impact and visibility that requires the gathered competence of a multidisciplinary team of investigators in order to be solved. The added value from collaboration between WASP and DDLS, but also within each of the programs, should be clearly emphasized. Scientific novelty, originality and impact, as well as their relevance to Swedish industry and/or society are important.

This call aims to provide funding for research investigating the human and social challenges of data-driven strategies developed and applied within the life sciences. The research should aim to increase the understanding of how using artificial intelligence (AI), autonomous systems, and data-driven methodologies has effects and consequences in the life sciences, medicine, and/or society.

For a full description of the call, see this page


No cookies are used.
Anubis 2.9.0